RecruitingNCT07472075
Melatonin Versus Placebo for Bipolarity
Medication studyAges 18–70Denmark
Understand this study
Who could participate?
Listed age limits: 18 years to 70 years.
- Listed locations
- FrederiksbergSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 8, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 200
- Sponsor
- Lars Vedel Kessing
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Denmark
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT07472075
- Official title
Show the full official title
Melatonin Versus Placebo for Bipolar Disorder - a Double Blinded Randomised Controlled Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Frederiksberg
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Lars Vedel Kessing.
Does this study involve medication?
Yes. The study involves medication, including Melatonin and Placebo.
Who can participate?
Listed age limits: 18 years to 70 years.
Is this study still recruiting?
The registry lists this study as recruiting.
